Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Friday Is Your Last Chance To Buy Golden Ocean Group Before The Dividend Payout

Friday, May 27 marks the last chance for investors to receive the next dividend payout from Golden Ocean Group (NASDAQ:GOGL).

Moleculin Biotech Doses Healthy Volunteers For Covid-19 In Early-Stage Study Of WP1122

Moleculin Biotech Doses Healthy Volunteers For Covid-19 In Early-Stage Study Of WP1122

Moleculin Biotech, Inc. (NASDAQ: MBRX) announced dosing of subjects in its Phase 1a clinical study of WP1122 in healthy volunteers for the treatment of COVID-19.

Viomi Technology Co's Earnings: A Preview

Viomi Technology Co's Earnings: A Preview

Viomi Technology Co (NASDAQ:VIOT) is set to give its latest quarterly earnings report on Friday, 2022-05-27. Here's what investors need to know before the announcement. Analysts estimate that Viomi Technology Co will report an earnings per share (EPS) of $0.28.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Why Baozun Shares Are Rising Today

Baozun Inc (NASDAQ:BZUN) reported a first-quarter FY22 revenue decline of 1.8% year-on-year to $312.99 million, beating the consensus of $283.85 million. Drivers: Gross Merchandise Volume (GMV) rose 28.4% Y/Y to RMB17 billion. Distribution GMV decreased 28.8% Y/Y to RMB764.6 million. The non-distribution GMV climbed 33.4% Y/Y to RMB16.2 billion. Segments: Product sales revenue declined 29.9%…

CytomX Therapeutics Initiates Dosing in Early-Stage Study Of Solid Tumor Settings

CytomX Therapeutics, Inc. (NASDAQ: CTMX) initiated enrolment by dosing first patient in a Phase 1 dose-escalation study of CX-904 for patients with advanced solid tumors.

Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced topline data from its Phase 1/2 trial of galinpepimut-S (GPS) in WT1(+) relapsed or refractory platinum-resistant advanced metastatic ovarian cancer. The trial evaluated SELLAS' peptide immunotherapeutic combined with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab). Data from 15 patients enrolled in the study has been preliminarily analyzed. Final…

inkl

Read news from The Economist, FT, and more,
with one subscription

United Fire Group Earnings Perspective: Return On Capital Employed

United Fire Group Earnings Perspective: Return On Capital Employed

Pulled from Benzinga Pro data, United Fire Group (NASDAQ:UFCS) posted Q1 earnings of $28.35 million, an increase from Q4 of 50.9%. Sales dropped to $245.01 million, a 10.09% decrease between quarters.

Looking Into Insight Enterprises's Return On Capital Employed

Looking Into Insight Enterprises's Return On Capital Employed

Pulled from Benzinga Pro data, Insight Enterprises (NASDAQ:NSIT) showed a loss in earnings since Q4, totaling $56.63 million. Sales, on the other hand, increased by 3.31% to $2.65 billion during Q1.

Lamar Advertising Earnings Perspective: Return On Invested Capital

Lamar Advertising Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q1, Lamar Advertising (NASDAQ:LAMR) earned $92.15 million, a 25.27% increase from the preceding quarter. Lamar Advertising's sales decreased to $451.39 million, a 8.73% change since Q4.

Vonage Hldgs's Return on Invested Capital Insights

Vonage Hldgs's Return on Invested Capital Insights

According to Benzinga Pro data, during Q1, Vonage Hldgs (NASDAQ:VG) posted sales of $358.83 million. Earnings were up 22.7%, but Vonage Hldgs still reported an overall loss of $17.12 million.

Aeglea BioTherapeutics Earnings Perspective: Return On Capital Employed

Aeglea BioTherapeutics Earnings Perspective: Return On Capital Employed

Aeglea BioTherapeutics (NASDAQ:AGLE) brought in sales totaling $1.36 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 19.51%, resulting in a loss of $24.44 million.

Why Nvidia Shares Are On The Move Today

Why Nvidia Shares Are On The Move Today

NVIDIA Corp (NASDAQ: NVDA) shares are trading lower Thursday after the company reported financial results and issued guidance below analyst estimates.

Broadcom To Acquire VMware In $61B Deal: What Investors Need To Know

Broadcom To Acquire VMware In $61B Deal: What Investors Need To Know

Broadcom Inc (NASDAQ: AVGO) on Thursday announced it will acquire Vmware Inc (NYSE: VMW) in a cash-and-stock transaction that values the multi-cloud company at approximately $61 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

'Highest-Quality Growth Stock:' Nvidia Analyst Shrugs Off Gloomy Guidance

Nvidia Corporation (NASDAQ: NVDA) cast a pall of gloom on the tech sector on Wednesday by providing underwhelming guidance for the second quarter.

Why Dollar Tree Shares Are Rallying Today

Dollar Tree Inc (NASDAQ:DLTR) reported first-quarter FY22 sales growth of 6.5% year-on-year to $6.90 billion, beating the consensus of $6.76 billion. Enterprise same-store sales increased 4.4%. Same-store sales for Dollar Tree increased 11.2%. Family Dollar same-store sales decreased 2.8%. Gross profit for the quarter rose 19.2% Y/Y to $2.34 billion, and the gross margin…

The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review

Here's a roundup of top developments in the biotech space over the last 24 hours:

Recap: Jack In The Box Q2 Earnings

Jack In The Box (NASDAQ:JACK) reported its Q2 earnings results on Thursday, May 26, 2022 at 08:30 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100’s of premium titles.
One news app.

Recap: Chindata Group Holdings Q1 Earnings

Chindata Group Holdings (NASDAQ:CD) reported its Q1 earnings results on Thursday, May 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

EXCLUSIVE: Grove Launches Medicinal Mushroom Product Line

Grove Inc (NASDAQ: GRVI) has launched its newest product line of mushroom extracts, Cure Mushrooms, set to take advantage of the growing demand in the medicinal mushroom space.

Qualcomm Chief Sees Prospects In High-End Smartphones, Meta Partnership Thanks To Augmented and Virtual Reality

In an interview at the World Economic Forum, Qualcomm Inc (NASDAQ:QCOM) CEO Cristiano Amon talked about growth as consumers increasingly chased "better phones," Reuters reports. Qualcomm's share with devices like the Samsung Galaxy grew from 40% share to over 75%. Qualcomm's technology powers augmented and virtual reality devices, including those made by Facebook…

Morning Brief: Top Financial Stories Dominating on Thursday, May 26

CNBC Two Major Tech Deals Come Under UK Government Scrutiny

Meta And 3 Other Stocks Insiders Are Selling

US crude oil futures traded higher this morning on Thursday. Investors, meanwhile, focused on some notable insider trades.

Why Baidu Shares Are Gaining Today

Baidu, Inc (NASDAQ:BIDU) reported first-quarter FY22 revenue growth of 1% year-on-year to $4.48 billion, beating the consensus of $4.18 billion. Segments: Baidu's Core revenue increased 4% Y/Y to $3.37 billion; Online marketing revenue declined 4% Y/Y to $2.47 billion, and Non-online marketing revenue jumped 35% Y/Y to $903 million, driven by cloud and other AI-powered businesses.…

Elon Musk Says Earth Is 'Basically Empty' And City Folks Are Just Living In Illusion

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk expanded on his previous commentary on the human population on Wednesday. What Happened: Musk said on Twitter that “[Humans] are absurdly concentrated on a tiny percentage of Earth’s surface.”

1 … 351 352 353 354

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Virtual reality

Augmented reality

Places

280,796 stories

114,988 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play